Immune-based Machine learning Prediction of Diagnosis and Illness State in Schizophrenia and Bipolar Disorder.
Katrien SkorobogatovLivia De PickerChing-Lien WuMarianne FoiselleJean-Romain RichardWahid BoukouaciJihène BouassidaKris LaukensPieter MeysmanPhilippe le CorvoisierCaroline BarauManuel MorrensRyad TamouzaMarion LeboyerPublished in: Brain, behavior, and immunity (2024)
This study highlights the potential of using immune-based measures to build predictive classification models in schizophrenia and bipolar disorder, with IL-6, TNF-ɑ, IFN-γ, QUINO and PICO as key candidates. While machine learning models successfully distinguished schizophrenia and bipolar disorder from controls, the challenges in differentiating schizophrenic from bipolar patients likely reflect shared immunological pathways by the both disorders and confounding by a larger state-specific effect. Larger multi-centric studies and multi-domain models are needed to enhance reliability and translation into clinic.
Keyphrases
- bipolar disorder
- machine learning
- major depressive disorder
- end stage renal disease
- artificial intelligence
- ejection fraction
- newly diagnosed
- deep learning
- chronic kidney disease
- big data
- rheumatoid arthritis
- prognostic factors
- immune response
- primary care
- dendritic cells
- computed tomography
- magnetic resonance imaging
- climate change